Undiagnosed Liver Disease May Be Common in Patients With Dementia
(MedPage Today) -- Significant numbers of patients with dementia may have undiagnosed liver disease, and hepatic encephalopathy may be contributing to their cognitive impairment, said authors of a national cohort study.
In 177,422 U.S. veterans... (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - January 31, 2024 Category: Primary Care Source Type: news
With clinical data in hand, trio of Bay Area biotechs raise collective $1.1 billion
The companies are pushing forward against fibrosis in fatty liver disease, to stop a dangerous kidney condition or to prevent pneumonia, and their latest news was rewarded by Wall Street investors. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - January 31, 2024 Category: Biotechnology Authors: Ron Leuty Source Type: news
GLP1 Agonists Reduce Major Adverse Liver Outcomes in Chronic Liver Disease
MONDAY, Jan. 29, 2024 -- For patients with chronic liver disease and type 2 diabetes, glucagon-like peptide-1 receptor (GLP1) agonists may result in a lower risk for major adverse liver outcomes (MALO), according to a study published online Jan. 22... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 29, 2024 Category: Pharmaceuticals Source Type: news
Alcohol-Linked Fatty Liver Disease More Fatal for Women
MONDAY, Jan 29, 2024 -- Fatty liver disease can cause liver damage and can be one health effect of long-term heavy drinking. Now, research shows that the illness can prove even more deadly for women who drink than for men.Also called steatotic... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 29, 2024 Category: General Medicine Source Type: news
Sagimet's Shares Hit New High as Fatty Liver Disease Drug Shows Promise in Study Sagimet's Shares Hit New High as Fatty Liver Disease Drug Shows Promise in Study
Sagimet Biosciences said on Monday its experimental drug to treat a fatty liver disease significantly reduced the symptoms in a mid-stage study, sending the drug maker ' s...Reuters Health Information (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - January 22, 2024 Category: Internal Medicine Tags: Gastroenterology Source Type: news
IIL launches first indigenous Hepatitis A vaccine
Priced at ?2,150 per dose, it is a two-dose vaccine in which the first dose is administered at above 12 months of age and the second dose is given at least after 6 months of the first dose. The vaccine is also recommended for individuals who are at risk of exposure or travel to the regions with high hepatitis A prevalence. In addition to this people with occupational risk of infection and suffering from chronic liver diseases also need Hepatitis A vaccination. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 19, 2024 Category: Pharmaceuticals Source Type: news
Subclasses of Steatotic Liver Disease Can Help Determine Prognosis
(MedPage Today) -- The new nomenclature for classifying steatotic liver disease (SLD) can help clinicians determine distinct prognoses, with the integration of alcohol intake as an aid in risk stratification, according to an analysis of a prospective... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - January 18, 2024 Category: Psychiatry Source Type: news
Guidelines Developed for Management of Alcohol-Associated Liver Disease
FRIDAY, Jan. 12, 2024 -- In a clinical guideline issued by the American College of Gastroenterology and published in the January issue of the American Journal of Gastroenterology, recommendations are presented for the management of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 12, 2024 Category: Pharmaceuticals Source Type: news
Assessment of lower limb muscle strength can predict fall risk in patients with chronic liver disease - Takada H, Yamashita K, Osawa L, Komiyama Y, Muraoka M, Suzuki Y, Sato M, Kobayashi S, Yoshida T, Takano S, Maekawa S, Enomoto N.
Falls are caused by a combination of factors, including loss of lower limb muscle strength (LMS), and associated with declined performance status (PS). Age-related sarcopenia is generally associated with decreased muscle mass and strength of lower limb mus... (Source: SafetyLit)
Source: SafetyLit - January 8, 2024 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news
'I'm a GP - here are early warning signs of fatty liver disease you might be ignoring'
Recent studies have estimated that one in three of us have fatty liver disease, but it's not always easy to know when you've got it. (Source: Daily Express - Health)
Source: Daily Express - Health - January 5, 2024 Category: Consumer Health News Source Type: news
Is There a Safe Alcohol Limit in Early Liver Disease? Is There a Safe Alcohol Limit in Early Liver Disease?
Adults with steatotic liver disease at lower risk for advanced fibrosis may be able to safely consume up to half of a standard US drink per day without increasing their risk of dying.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - January 2, 2024 Category: Gastroenterology Tags: Gastroenterology Source Type: news
Aching pain on one side of the body could signal fatty liver disease
This symptom could be easily dismissed as just a stomach ache or indigestion. (Source: Daily Express - Health)
Source: Daily Express - Health - December 29, 2023 Category: Consumer Health News Source Type: news
Study Looks at Alcohol Intake, Mortality Link in Steatotic Liver Disease
THURSDAY, Dec. 14, 2023 -- For individuals with steatotic liver disease (SLD) at low risk for advanced fibrosis, there is a nonlinear association between alcohol consumption and mortality, with increased risk at or above consumption of 7.4 g/day,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 15, 2023 Category: Pharmaceuticals Source Type: news
Science ’s 2023 Breakthrough of the Year: Weight loss drugs with a real shot at fighting obesity
Show / hide sections navigation
2023 Breakthrough of the Year
Runners-up
Breakdowns
Video
Obesity plays out as a private struggle and a public health crisis. In the United States, about 70% of adults are affected by excess weight, and in Europe that number is more than half. The stigma against fat can be crushing; its risks, life-threatening. Defined as a body mass index of at least 30, obesity is thought to power type 2 diabetes, heart disease, arthritis, fatty liver disease, and certain cancers.
Yet drug treatments...
Source: ScienceNOW - December 14, 2023 Category: Science Source Type: news
Early closing of hotels: Impacts on alcohol consumption, drunkenness, liver disease and injury mortality - Dunt DR, Jiang H, Room R.
INTRODUCTION: Early (six o'clock) closing of hotels was introduced in 1916 in Australia to curb heavy drinking. It lasted between 21 and 51 years in four Australian states. The aim of this study is to assess the impact of early closing on alcohol consumpti... (Source: SafetyLit)
Source: SafetyLit - December 8, 2023 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news
